288 related articles for article (PubMed ID: 1637346)
1. Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids.
Liang T; Liao S
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):557-62. PubMed ID: 1637346
[TBL] [Abstract][Full Text] [Related]
2. Binding of a 4-methyl-4-aza-steroid to 5 alpha-reductase of rat liver and prostate microsomes.
Liang T; Heiss CE; Ostrove S; Rasmusson GH; Cheung A
Endocrinology; 1983 Apr; 112(4):1460-8. PubMed ID: 6832056
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of steroid 5 alpha-reductase and its effects on testosterone hydroxylation by rat liver microsomal cytochrome P-450.
Sonderfan AJ; Parkinson A
Arch Biochem Biophys; 1988 Aug; 265(1):208-18. PubMed ID: 3415243
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
Liang T; Heiss CE
J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637
[TBL] [Abstract][Full Text] [Related]
5. Photoaffinity labeling of steroid 5 alpha-reductase of rat liver and prostate microsomes.
Liang T; Cheung AH; Reynolds GF; Rasmusson GH
J Biol Chem; 1985 Apr; 260(8):4890-5. PubMed ID: 3988737
[TBL] [Abstract][Full Text] [Related]
6. In vivo assay for conversion of testosterone to dihydrotestosterone by rat prostatic steroid 5 alpha-reductase and comparison of two inhibitors.
Toomey RE; Goode RL; Petrow V; Neubauer BL
Prostate; 1991; 19(1):63-72. PubMed ID: 1876537
[TBL] [Abstract][Full Text] [Related]
7. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.
Liang T; Heiss CE; Cheung AH; Reynolds GF; Rasmusson GH
J Biol Chem; 1984 Jan; 259(2):734-9. PubMed ID: 6693392
[TBL] [Abstract][Full Text] [Related]
8. 5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids.
Pham H; Ziboh VA
J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):393-400. PubMed ID: 12589947
[TBL] [Abstract][Full Text] [Related]
9. Anti-5 alpha-reductase autoantibodies in the serum of patients with prostatic cancer.
Liang T; Hiipakka RA; Stebbins J; Liao S
J Clin Endocrinol Metab; 1990 Dec; 71(6):1666-8. PubMed ID: 2229323
[TBL] [Abstract][Full Text] [Related]
10. Effect of a 4-methyl-4-aza steroid on androgen metabolism by rat ventral prostate epithelial and stromal cell cultures: selective inhibition of 5 alpha-reductase activity.
Orlowski J; Clark AF
Prostate; 1988; 13(4):289-97. PubMed ID: 3217276
[TBL] [Abstract][Full Text] [Related]
11. The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450.
Di Augustine RP; Fouts JR
Biochem J; 1969 Nov; 115(3):547-54. PubMed ID: 4390924
[TBL] [Abstract][Full Text] [Related]
12. Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat.
Swinney DC
Drug Metab Dispos; 1990; 18(6):859-65. PubMed ID: 1981529
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
14. Kinetic mechanism of reduction of testosterone by hepatic 5 beta-reductase of chicken and inhibition of the reductase activity by a secosteroid, an azasteroid and glycyrrhetinic acid.
Yoshida M; Kuroki Y; Kobayashi E; Tamaoki B
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):29-36. PubMed ID: 1734934
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of brain prostaglandin D synthetase and prostaglandin D2 dehydrogenase by some saturated and unsaturated fatty acids.
Osama H; Narumiya S; Hayaishi O; Iinuma H; Takeuchi T; Umezawa H
Biochim Biophys Acta; 1983 Jul; 752(2):251-8. PubMed ID: 6407532
[TBL] [Abstract][Full Text] [Related]
16. Anti-androgenic activity of fatty acids.
Liu J; Shimizu K; Kondo R
Chem Biodivers; 2009 Apr; 6(4):503-12. PubMed ID: 19353546
[TBL] [Abstract][Full Text] [Related]
17. Identification of saturated and unsaturated fatty acids released during microsomal incubations.
Bushee JL; Liang G; Dunne CE; Harriman SP; Argikar UA
Xenobiotica; 2014 Aug; 44(8):687-95. PubMed ID: 24502389
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells.
Délos S; Iehlé C; Martin PM; Raynaud JP
J Steroid Biochem Mol Biol; 1994 Mar; 48(4):347-52. PubMed ID: 8142312
[TBL] [Abstract][Full Text] [Related]
19. Effect of unsaturated fatty acids and Ca2+ on phosphatidylinositol synthesis and breakdown.
Takenawa T; Nagai Y
J Biochem; 1982 Mar; 91(3):793-9. PubMed ID: 6281246
[TBL] [Abstract][Full Text] [Related]
20. Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapy.
Geldof AA; Meulenbroek MF; Dijkstra I; Bohlken S; Rao BR
J Cancer Res Clin Oncol; 1992; 118(1):50-5. PubMed ID: 1729259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
